GSK shares dive as weaker sales and mounting costs unnerve investors
British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drugBusiness live – latest upda...
France hit by debt sell-off as protests unnerve investors
After Macron condemned ‘unbridled violence’, difference between French and German 10-year borrowing costs widensBusiness live – latest updatesFrance w...